Eurizon Capital SGR SpA’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.9M Sell
74,478
-2,917
-4% -$767K 0.06% 237
2026
Q1
$20.6M Buy
77,395
+8,207
+12% +$2.22M 0.06% 235
2025
Q4
$17.4M Buy
+69,188
New +$18.4M 0.05% 221

Other funds holding LH

Eurizon Capital SGR SpA's LH Position: Q2 2026 in Review

Eurizon Capital SGR SpA reduced its Labcorp (LH) stake by 3.8% in Q2 2026, selling an estimated $767K and leaving 74,478 shares worth $20.9M. The position accounts for 0.06% of the portfolio, ranked #237.

Eurizon Capital SGR SpA first reported a position in LH in Q4 2025 and has held it in 3 quarters since. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Eurizon Capital SGR SpA held 74,478 shares of Labcorp worth $20.9M as of Q2 2026.
  • Eurizon Capital SGR SpA sold 2,917 Labcorp shares in Q2 2026, an estimated $767K.
  • Labcorp made up 0.06% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #237 holding.
  • Eurizon Capital SGR SpA first reported a position in Labcorp in Q4 2025 and has held it in 3 quarters since.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.